KEGG: spo:SPBC1604.18c
STRING: 4896.SPBC1604.18c.1
SPBC1604.18c is an uncharacterized protein in Schizosaccharomyces pombe (fission yeast) that is predicted to function as an ESCRT III complex subunit. The ESCRT (Endosomal Sorting Complex Required for Transport) machinery plays crucial roles in membrane remodeling processes, including multivesicular body formation, cytokinetic abscission, and viral budding. Studying SPBC1604.18c contributes to our understanding of fundamental cellular processes across eukaryotes, as the ESCRT machinery is highly conserved. Antibodies against this protein allow researchers to investigate its expression, localization, and interactions within the cell .
The commercially available SPBC1604.18c antibodies are typically polyclonal antibodies raised in rabbits against the Schizosaccharomyces pombe protein. These antibodies are purified through antigen-affinity methods and are of IgG isotype. They are specifically designed to recognize epitopes of the uncharacterized protein C1604.18c (SPBC1604.18c), which functions as a predicted ESCRT III complex subunit. The antibodies are validated for research applications including ELISA and Western Blot techniques to ensure proper identification of the antigen .
While SPBC1604.18c is predicted to be an ESCRT III complex subunit, its precise function remains to be fully characterized. The ESCRT III complex generally mediates membrane deformation and scission events. Based on homology with other ESCRT III components, SPBC1604.18c likely contributes to the formation of spiral filaments that constrict membranes during processes like multivesicular body biogenesis. Its functional relationships with other ESCRT components such as Vps24, Vps20, Snf7, Did2, and Did4 (all present in S. pombe) would be important for complete understanding of the ESCRT machinery in fission yeast .
The SPBC1604.18c antibodies have been validated for specific research applications including:
Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative detection of SPBC1604.18c protein
Western Blotting (WB) - For identification of the protein in cell or tissue lysates
These applications enable researchers to study protein expression levels, confirm protein identity, and potentially investigate protein modifications. When designing experiments, researchers should consider the antibody concentration, incubation conditions, and appropriate controls to ensure reliable results .
While the commercially available SPBC1604.18c antibodies are primarily validated for ELISA and Western Blot applications, researchers interested in immunofluorescence microscopy should perform additional validation steps. This includes:
Titration experiments to determine optimal antibody concentration
Specificity testing using knockout or knockdown controls
Co-localization studies with known ESCRT III markers
Comparison with GFP-tagged SPBC1604.18c expression patterns
Fixation methods can significantly impact epitope availability—both paraformaldehyde and methanol fixation should be tested to determine the optimal protocol for SPBC1604.18c detection in immunofluorescence applications .
For studying protein-protein interactions involving SPBC1604.18c, researchers can employ:
Co-immunoprecipitation (Co-IP) - Using the SPBC1604.18c antibody to pull down the protein and its interaction partners
Proximity ligation assay (PLA) - For visualizing and quantifying protein interactions in situ
Immunoprecipitation followed by mass spectrometry - To identify novel interaction partners
When designing such experiments, it's critical to optimize lysis conditions to maintain protein interactions while efficiently extracting SPBC1604.18c. Gentle detergents like CHAPS or digitonin may better preserve protein complexes compared to stronger detergents like SDS. Cross-linking approaches may also be valuable for capturing transient interactions within the ESCRT III complex .
For optimal Western blot results with SPBC1604.18c antibodies, researchers should consider the following protocol parameters:
| Parameter | Recommended Conditions |
|---|---|
| Sample preparation | Cell lysis in RIPA buffer with protease inhibitors |
| Protein amount | 20-50 μg total protein per lane |
| Gel percentage | 10-12% SDS-PAGE |
| Transfer conditions | Wet transfer at 100V for 1 hour or 30V overnight |
| Blocking solution | 5% non-fat dry milk in TBST, 1 hour at room temperature |
| Primary antibody dilution | 1:500 to 1:2000 (requires optimization) |
| Primary antibody incubation | Overnight at 4°C |
| Secondary antibody | Anti-rabbit HRP-conjugated, 1:5000 dilution |
| Detection method | Enhanced chemiluminescence (ECL) |
Researchers should always run appropriate controls, including positive controls (S. pombe lysate) and negative controls (unrelated yeast species lysate). The predicted molecular weight of SPBC1604.18c should be considered when interpreting bands, though post-translational modifications may cause shifts in apparent molecular weight .
Effective sample preparation is crucial for SPBC1604.18c detection. For optimal results:
Harvest yeast cells during logarithmic growth phase for consistent expression
Use mechanical disruption (glass beads) combined with a suitable lysis buffer containing protease inhibitors
Optimize lysis conditions: RIPA buffer works well for general applications, while NP-40 or Triton X-100 based buffers may better preserve protein complexes
Clarify lysates by centrifugation at 14,000 × g for 15 minutes
Quantify protein concentration using Bradford or BCA assay
Store samples at -80°C with glycerol to prevent freeze-thaw degradation
When working with membrane-associated proteins like ESCRT III components, consider including mild sonication steps to enhance extraction from membrane fractions. Phosphatase inhibitors may also be included if studying phosphorylation states of SPBC1604.18c .
Validating antibody specificity is essential for reliable research. For SPBC1604.18c antibodies, consider:
Genetic validation: Testing antibody reactivity in SPBC1604.18c deletion strains
Molecular validation: Using recombinant SPBC1604.18c protein as a positive control
Peptide competition assays: Pre-incubating antibody with immunizing peptide to block specific binding
Cross-reactivity assessment: Testing against closely related ESCRT III proteins
Expression correlation: Correlating antibody signal with mRNA levels using qPCR
Researchers should also consider comparing multiple commercial antibodies targeting different epitopes of SPBC1604.18c to confirm consistent detection patterns. Documentation of validation experiments increases confidence in research findings and should be included in publications .
Investigating ESCRT III complex assembly dynamics requires sophisticated approaches:
Immunoprecipitation-based kinetic studies: Using SPBC1604.18c antibodies to pull down complexes at different time points after stimulus
Super-resolution microscopy: Combining SPBC1604.18c antibodies with super-resolution techniques like STORM or PALM to visualize complex formation
In vitro reconstitution assays: Using purified components and antibodies to track assembly on artificial membranes
FRAP (Fluorescence Recovery After Photobleaching): Combined with antibody labeling to study protein turnover within complexes
Researchers should consider membrane recruitment kinetics, as ESCRT III components typically transition from cytosolic to membrane-bound states during function. Quantitative analysis of colocalization with other ESCRT components (Vps24, Vps20, Snf7, Did2, and Did4) can provide insights into assembly order and stoichiometry .
Comparative functional analysis of SPBC1604.18c with homologs requires careful experimental design:
Complementation studies: Testing if homologs can rescue SPBC1604.18c deletion phenotypes
Domain swapping experiments: Creating chimeric proteins to identify functional regions
Interaction conservation analysis: Using antibodies to compare interaction partners across species
Localization pattern comparison: Examining subcellular distribution in different organisms
When designing cross-species studies, researchers should account for differences in cell biology between S. pombe and other model organisms. Sequence alignment analysis can identify conserved functional domains to guide experimental design. The development of epitope-specific antibodies targeting conserved regions would facilitate cross-species comparisons .
Investigating post-translational modifications (PTMs) of SPBC1604.18c requires specialized techniques:
Phospho-specific antibodies: Development of antibodies recognizing phosphorylated forms
Mass spectrometry: For comprehensive PTM mapping following immunoprecipitation
2D gel electrophoresis: To separate protein isoforms before Western blotting
Phos-tag SDS-PAGE: For enhanced separation of phosphorylated species
The functional significance of identified PTMs can be studied using:
Site-directed mutagenesis to create non-modifiable variants
Phosphatase treatments to remove modifications
Kinase inhibitors to prevent phosphorylation
Cell cycle synchronization to examine temporal regulation
When integrating multiple analytical approaches, researchers can build comprehensive models of how PTMs regulate SPBC1604.18c function within the ESCRT machinery .
Researchers may encounter several challenges when working with SPBC1604.18c antibodies:
| Issue | Possible Causes | Solutions |
|---|---|---|
| Weak or no signal | Low expression level, epitope masking, antibody degradation | Increase protein amount, try different lysis methods, use fresh antibody |
| High background | Insufficient blocking, excessive antibody concentration, non-specific binding | Optimize blocking conditions, titrate antibody, include additional washing steps |
| Multiple bands | Cross-reactivity, protein degradation, splice variants | Validate specificity, add protease inhibitors, compare with predicted MW |
| Inconsistent results | Variable expression levels, technical variation | Standardize growth conditions, develop robust protocols, include internal controls |
For challenging applications, consider sample enrichment techniques like subcellular fractionation to concentrate SPBC1604.18c before detection. Testing multiple antibody lots can also help identify lot-to-lot variation that may impact experimental reproducibility .
Proper antibody handling is essential for maintaining activity:
Storage conditions: Store concentrated antibody at -20°C or -80°C in small aliquots to avoid freeze-thaw cycles
Working dilutions: Prepare fresh from concentrated stock, or store at 4°C with preservatives for up to 2 weeks
Preservatives: Consider adding sodium azide (0.02%) to prevent microbial growth in stored working dilutions
Temperature sensitivity: Avoid prolonged exposure to room temperature
Documentation: Maintain detailed records of antibody source, lot number, and validation experiments
Researchers should perform periodic quality control tests on stored antibodies to ensure continued reactivity. For valuable antibody preparations, consider adding protein carriers like BSA (1%) to prevent adsorption to container surfaces during long-term storage .
Determining optimal antibody concentration requires systematic titration:
Western blotting titration:
Test serial dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000)
Evaluate signal-to-noise ratio at each concentration
Select concentration providing specific signal with minimal background
ELISA titration:
Prepare antibody dilution series (typically 1:100 to 1:10,000)
Plot standard curves at each concentration
Determine limit of detection and dynamic range
Choose concentration balancing sensitivity and specificity
Documentation guidance:
Record all titration experiments in laboratory notebooks
Include images of titration results in supplementary materials for publications
Report specific antibody concentrations rather than dilution factors when possible
Each new application or sample type may require re-optimization of antibody concentration. Including positive and negative controls in titration experiments helps establish valid working ranges .
Quantitative analysis of SPBC1604.18c Western blots requires rigorous methodology:
Normalization approaches:
Use housekeeping proteins (e.g., actin, tubulin) as loading controls
Consider total protein normalization methods (e.g., Ponceau S staining)
Validate stability of reference proteins under experimental conditions
Quantification software:
ImageJ/Fiji for basic densitometry
Commercial software packages for advanced analysis
Standardize analysis parameters across experiments
Statistical considerations:
Run technical replicates (minimum n=3) for each biological sample
Perform appropriate statistical tests based on experimental design
Report both raw and normalized values when possible
When monitoring changes in SPBC1604.18c expression, consider establishing a linear dynamic range for quantification by loading a dilution series of a reference sample. This helps ensure that measurements fall within the linear response range of both antibody binding and detection systems .
Comprehensive ESCRT studies require integrative approaches:
Correlation analysis: Examine relationships between expression levels of multiple ESCRT components
Pathway reconstruction: Build interaction networks incorporating SPBC1604.18c data
Multi-omics integration: Combine antibody-based protein data with transcriptomics and proteomics
Temporal profiling: Track dynamic changes in multiple ESCRT components during cellular processes
When designing integrative studies:
Standardize sample preparation methods across all targets
Use consistent normalization strategies
Develop computational frameworks to handle multi-dimensional data
Consider both stoichiometric and functional relationships between components
Visualization tools such as heatmaps, interaction networks, and temporal profiles can help communicate complex relationships between SPBC1604.18c and other ESCRT machinery components .
Rigorous controls are essential for reliable antibody-based experiments:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive control | Confirm antibody reactivity | S. pombe wild-type lysate or recombinant protein |
| Negative control | Assess specificity | SPBC1604.18c deletion strain lysate |
| Loading control | Normalize for protein amount | Housekeeping protein or total protein stain |
| Secondary-only control | Detect non-specific secondary binding | Omit primary antibody |
| Isotype control | Account for non-specific IgG binding | Non-targeted rabbit IgG |
| Peptide competition | Verify epitope specificity | Pre-incubate antibody with immunizing peptide |
For genetic manipulation studies, researchers should include appropriate controls such as empty vector transformants and rescue experiments with wild-type SPBC1604.18c to confirm phenotype specificity. When performing quantitative comparisons, standardization samples should be included on each gel/blot to account for inter-assay variation .
Both antibody-based detection and genetic tagging have distinct advantages and limitations:
| Aspect | Antibody-Based Detection | Genetic Tagging (e.g., GFP fusion) |
|---|---|---|
| Native protein | Detects endogenous protein without modification | Protein is modified by tag addition |
| Expression level | Detects natural expression levels | May alter expression or regulation |
| Live imaging | Limited to fixed samples | Enables live-cell imaging |
| Spatial resolution | Depends on antibody specificity and detection method | Usually highly specific |
| Temporal dynamics | Snapshot of fixed timepoints | Can track real-time dynamics |
| Technical complexity | Requires optimization but no genetic modification | Requires strain engineering |
| Post-translational modifications | Can detect with specific antibodies | May interfere with modifications |
For comprehensive studies, researchers should consider combining both approaches: using antibodies to validate GFP-fusion protein behavior and using GFP-tagged strains to extend findings to live-cell contexts. When genetic tagging is employed, C-terminal and N-terminal tags should be compared, as tag position can affect protein function differently .
Multiple complementary approaches can enhance understanding of SPBC1604.18c:
Genetic approaches:
CRISPR/Cas9-mediated gene editing
Conditional degron systems for temporal control
Suppressor screening to identify functional relationships
Synthetic genetic array (SGA) analysis
Biochemical methodologies:
In vitro reconstitution of ESCRT complexes
Liposome-based membrane deformation assays
Structural studies (X-ray crystallography, Cryo-EM)
Cross-linking mass spectrometry (XL-MS)
Imaging techniques:
Correlative light and electron microscopy (CLEM)
Single-molecule localization microscopy
High-content screening approaches
Label-free imaging methods
Integrating multiple methodologies provides stronger evidence than any single approach. Researchers should carefully select complementary methods based on specific research questions about SPBC1604.18c function .
Comprehensive comparative studies require systematic approaches:
Strain comparison considerations:
Standardize growth media and conditions
Harvest cells at equivalent growth phases
Use internal standards for cross-strain normalization
Consider genetic background effects on expression
Environmental variable testing:
Develop a matrix of conditions (temperature, nutrients, stress factors)
Implement time-course studies to capture dynamic responses
Use appropriate statistical methods for multifactorial experiments
Consider interaction effects between variables
Quantification approaches:
Absolute quantification using purified standards
Relative quantification with consistent reference samples
Digital PCR for transcript quantification correlation
Automated image analysis for high-throughput microscopy
When designing comparative studies, researchers should establish clear hypotheses about how SPBC1604.18c function might vary across conditions, based on known ESCRT III biology in different environmental contexts. This guides experimental design and helps prioritize the most informative comparisons .